Home › Funds › Nykredit A/S › ABBV

Nykredit A/S position in ABBV

Abbvie Inc · Health Care

Nykredit A/S reported holding 623,539 shares of ABBV (Abbvie Inc) in its Q3 2026 13F filing — a position valued at US$163.1M, representing 0.60% of its reported portfolio and ranking #29 among its reported holdings. Nykredit A/S has disclosed ABBV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)623.54K sh
Reported value held$163.11M
Portfolio Weight0.60%
First reportedQ2 2026
Last changeAdd
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How Nykredit A/S's ABBV position evolved

Nykredit A/S first disclosed a stake in ABBV in Q2 2026 at 596,240 shares (US$150.0M). The position peaked in Q3 2026 at 623,539 shares, worth US$163.1M. Across 2 filings, Nykredit A/S increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 623,539 shares valued at US$163.1M — an increase of 27,299 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 596.24K $150.04M New
Q3 2026 623.54K $163.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (Abbvie Inc) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Nykredit A/S held ABBV?

Nykredit A/S has disclosed ABBV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Nykredit A/S's current position in ABBV?

As of Q3 2026, Nykredit A/S holds 623.54K shares of ABBV (Abbvie Inc), valued at $163.11M, representing 0.60% of its reported portfolio and ranking #29.

Has Nykredit A/S been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Nykredit A/S increased its position in ABBV. The position peaked in Q3 2026 at 623.54K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.